```html

Zika Virus Fever

What is Zika virus fever?

Zika virus fever is an acute, usually mild, viral illness caused by infection with the Zika virus, a member of the Flaviviridae family. The virus is transmitted primarily through the bite of infected Aedes mosquitoes (especially A. aegypti and A. albopictus), but it can also be spread through sexual contact, blood transfusion, and from a pregnant woman to her fetus.

Most people who contract Zika experience a short‑lasting fever along with other flu‑like symptoms. Although the infection is often self‑limiting, Zika has gained worldwide attention because of its association with severe birth defects (notably micro‑microcephaly) and neurological complications such as Guillain‑Barré syndrome.

Sources: CDC, WHO, Mayo Clinic

Common Causes

While Zika virus fever is itself caused by the Zika virus, the term “causes” in a clinical context often refers to the various ways a person can become infected or conditions that mimic the disease. Below are the most frequent sources of exposure and differential diagnoses that clinicians consider:

• Bitten by an infected Aedes mosquito – the primary route.
• Unprotected sexual contact with an infected partner (vaginal, anal, or oral).
• Blood transfusion or organ transplantation from a donor who was viremic.
• Vertical transmission – mother‑to‑fetus during pregnancy.
• Dengue virus infection – a related flavivirus with overlapping symptoms.
• Chikungunya virus infection – another mosquito‑borne illness that can cause fever and joint pain.
• Yellow fever – flavivirus that can be confused clinically.
• Enteroviral infections – such as non‑polio enteroviruses that cause rash and fever.
• Other viral exanthems – e.g., measles, rubella.
• Non‑infectious causes of rash and fever – drug reactions, autoimmune diseases.

Associated Symptoms

Only about 1 in 5 people infected with Zika develop noticeable symptoms. When they do appear, the classic triad includes:

• Fever – usually low grade (≤38.5 °C / ≤101.3 °F) and lasting 2‑7 days.
• Maculopapular rash – often starts on the face and spreads to the trunk and limbs.
• Conjunctivitis (pink eye) – non‑purulent, without discharge.

Additional, less specific manifestations may occur:

• Headache, especially behind the eyes
• Joint and muscle pain (arthralgia, myalgia)
• Fatigue and malaise
• Subtle swelling of the lymph nodes
• Occasional mild gastrointestinal upset (nausea, diarrhea)

In a minority of cases, neurologic complications develop weeks after the initial illness. These include:

• Guillain‑Barré syndrome (ascending weakness, tingling)
• Acute disseminated encephalomyelitis (ADEM)

Pregnant women infected with Zika are at risk for fetal complications such as:

• Microcephaly and other brain anomalies
• Intrauterine growth restriction
• Eye abnormalities (e.g., retinal lesions)

When to See a Doctor

Most healthy adults recover without medical intervention, but you should seek professional care promptly if you experience any of the following:

• Fever lasting longer than 7 days or a temperature >39 °C (102 °F).
• Severe headache, especially with neck stiffness or visual changes.
• Persistent or worsening joint pain that limits movement.
• Signs of neurological involvement (tingling, weakness, difficulty walking, facial droop).
• Pregnant women – any fever or rash warrants immediate evaluation, regardless of severity.
• Recent travel to an area with active Zika transmission combined with any of the symptoms above.

Early evaluation is essential for pregnant patients because timely testing can guide fetal monitoring and obstetric management.

Diagnosis

Because Zika’s symptoms overlap with many other viral infections, laboratory confirmation is key.

1. Clinical assessment

• Travel history to endemic regions within the past 14 days.
• Exposure risk (mosquito bites, sexual contact).
• Complete physical exam focusing on rash distribution, conjunctivitis, and neurologic status.

2. Laboratory testing

• Reverse‑transcriptase polymerase chain reaction (RT‑PCR) – detects viral RNA in blood, urine, or saliva. Most reliable within the first 7‑10 days of symptom onset.
• Serologic testing (IgM ELISA) – identifies antibodies after the first week; confirmatory plaque‑reduction neutralization test (PRNT) helps differentiate Zika from other flaviviruses.
• Urine testing – Zika RNA can persist longer in urine than in serum, extending the diagnostic window.

3. Additional evaluations (when indicated)

• Complete blood count (CBC) – may show mild leukopenia.
• Imaging (ultrasound) for pregnant women to assess fetal growth and brain development.
• Neurologic work‑up (nerve conduction studies, lumbar puncture) if Guillain‑Barré syndrome is suspected.

Treatment Options

There is no specific antiviral medication approved for Zika virus infection. Management is supportive and focuses on symptom relief and preventing complications.

Medical treatments

• Acetaminophen (paracetamol) – first‑line for fever and headache. Avoid NSAIDs (e.g., ibuprofen) until dengue has been ruled out, as these can increase bleeding risk.
• Antihistamines – may help relieve itch associated with rash.
• Corticosteroids – not routinely recommended; may be considered for severe inflammatory neurologic complications under specialist supervision.
• Intravenous immunoglobulin (IVIG) – used in Guillain‑Barré syndrome to speed recovery.

Home care measures

• Stay well‑hydrated – oral rehydration solutions or clear fluids.
• Rest in a cool, comfortable environment.
• Apply soothing lotions or calamine to reduce rash itching.
• Use a cool compress for conjunctival irritation.
• Monitor temperature twice daily and keep a symptom diary for follow‑up visits.

Prevention Tips

Because there is no vaccine for Zika (as of 2026), prevention focuses on avoiding mosquito bites and limiting other routes of transmission.

• Travel awareness – Check CDC and WHO travel advisories before visiting endemic areas.
• Use EPA‑registered insect repellents containing DEET, picaridin, IR3535, or oil of lemon eucalyptus. Reapply every 3‑4 hours.
• Wear protective clothing – long sleeves, pants, and socks; treat clothing with permethrin.
• Sleep under screened or air‑conditioned rooms to keep mosquitoes out.
• Eliminate standing water around homes (flower pots, buckets, tires) to reduce breeding sites.
• Safe sex practices – Use condoms or abstain for at least 3 months (men) or 2 months (women) after possible exposure, per CDC guidance.
• Blood safety – Blood banks now screen donations for Zika in high‑risk periods; inform clinicians if you have recent exposure.
• Pregnancy precautions – Women who are pregnant or planning pregnancy should avoid travel to areas with active Zika transmission.

Emergency Warning Signs

Key Take‑aways

• Zika virus fever is usually mild but can have serious consequences for pregnant women and the nervous system.
• Diagnosis relies on PCR or serology; clinical suspicion should be high after travel to endemic regions.
• Treatment is supportive; acetaminophen for fever, hydration, and rest are the mainstays.
• Prevention centers on mosquito bite avoidance, safe sexual practices, and travel caution.
• Seek urgent care for high fever, neurologic decline, severe dehydration, or any concerning signs during pregnancy.

References:

1. Centers for Disease Control and Prevention. Zika Virus. Accessed May 2026.
2. World Health Organization. Zika virus fact sheet. Updated 2024.
3. Mayo Clinic. Zika virus symptoms and causes. 2023.
4. National Institutes of Health. Zika Virus Infection. In: StatPearls, 2024.
5. Cleveland Clinic. Zika Virus. Reviewed 2025.

```